The Administrator of the Drug Enforcement Administration is issuing this final order to extend the temporary schedule I status of a range of Controlled Substances. This final order will extend the temporary scheduling for one year, or until the permanent scheduling action for these following substances is completed, whichever occurs first.
- 25I-NBOMe (November, 2015)
- PB-22 (February, 2016)
- 4-MEC (March, 2016)
Randox Toxicology exclusively provides a range of tests for Synthetic Cannabinoids, NBOMe and Bath Salts (α-PVP) across various platforms including Biochip Array Technology, ELISA and Homogeneous EIA. Our kits offer precision with <10% CV, offering highly accurate detection with superior correlation with GC/MS. Sensitive kits offer excellent cross-reactivity and unrivalled limits of detection on a range of routine and novel assays including New Psychoactive Substances. Our NBOMe and α-PVP ELISA test is the only viable method for detecting this scheduled I drug in your laboratory.